Skip to main content
WeightCited

Berberine 用于 代谢综合征

A 证据 多项大型临床试验一致显示出显著的益处。

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None vs: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance 效果: None None

研究人群: MCD diet-induced MASH C57BL/6J male mice

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Alzheimer's disease patients

Key Statistics

12

研究数量

1068

受试者

Positive

A

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

上限: 1,500 mg/day; GI side effects limit intake; potential drug interactions

研究中使用的剂量

剂量 持续时间 效果 N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

最佳服用时间: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

已报告的副作用

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

已知相互作用

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

可耐受最高摄入量: 1,500 mg/day; GI side effects limit intake; potential drug interactions

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Berberine help with 代谢综合征?
Based on 12 studies with 1,068 participants, there is strong evidence from multiple clinical trials that Berberine may support 代谢综合征 management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for 代谢综合征?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and 代谢综合征?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 1,068 total participants. The overall direction of effect is positive.

其他成分用于 代谢综合征

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。